Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
XB-PHENO-2348

Xla Wt + kmt2d MO, Schwenty-Lara J et al. (2020)

Experiment + Assay: Xla Wt + kmt2d MO + NF 42
Background: Xla.Portsmouth1EXRC
Manipulations:
Manipulation Type Reagent Target Gene Stage Treatment Area
morpholino injection kmt2d MO1 kmt2d.L
 NF stage 2 (2-cell) blastomere
Conditions:
Assay Type Assay Stages Antibody
in situ hybridization NF stage 42 to NF stage 42  
Anatomical Phenotypes: abnormal craniofacial region morphology, abnormal eye morphology, decreased size of the cranial skeleton
Human Disease Associations: Kabuki syndrome
Source: Fig1 A row3
Article: XB-ART-56551, PubMed